Stay updated on Immunotherapy Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. This does not affect the study details, eligibility criteria, or results displayed on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedLocations were updated to include a Maryland site. The Maryland Locations entry and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2. This change does not affect study details, results, or navigation; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the government funding operating status disclaimer that warned information may not be up to date, which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check76 days agoChange DetectedOnly minor layout and formatting changes are visible; there are no changes to core study details such as the title, NCT03190265, interventions, eligibility criteria, or outcomes. Enrollment numbers and study status remain unchanged.SummaryDifference0.4%

- Check104 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

Stay in the know with updates to Immunotherapy Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combo in Pancreatic Cancer Clinical Trial page.